Can I Get a Multidisciplinary Consult, Please? Systemic Immunotherapy and the Timing of Cytoreductive Nephrectomy

Eur Urol Focus. 2020 Jan 15;6(1):9-10. doi: 10.1016/j.euf.2019.05.013. Epub 2019 May 27.

Abstract

Patient selection is critical to determine who benefits from initial cytoreductive nephrectomy and who benefits from initial systemic treatment. Cytoreductive nephrectomy can no longer be considered a one-size-fits-all approach. Multidisciplinary evaluation is key.

MeSH terms

  • Carcinoma, Renal Cell / therapy*
  • Cytoreduction Surgical Procedures*
  • Humans
  • Immunotherapy* / methods
  • Kidney Neoplasms / therapy*
  • Nephrectomy / methods*
  • Patient Care Team